PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspostmenopausal osteoporosis
MeSH D015663 - postmenopausal osteoporosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010024:Osteoporosis
13 Companies
20 Drugs
$
Success rate
D015663: 
Postmenopausal osteoporosis
52 Companies
17 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAlendronate Alendronate  2008-02-06   
Ibandronic acid Ibandronic Acid Teva  2010-09-17   
Raloxifene Raloxifene  2014-03-04   
Raloxifene Raloxifene Teva  2010-04-29   
Zoledronic acid Zoledronic acid Teva Pharma  2012-08-15   
Teriparatide Teriparatide  2023-11-16   
Risedronate Risedronate  2007-10-05   
Glenmark PharmaceuticalsRaloxifene Raloxifene  2016-03-22   
MylanAlendronate Alendronate  2008-08-04   
Ibandronate Ibandronate  2012-03-19   
Risedronate Risedronate  2014-06-10   
RocheIbandronic acid Bondenza (previously Ibandronic Acid Roche)  2004-02-23   
Ibandronate Boniva 2023-05-06 2003-05-16   
Ibandronic acid Destara  1996-06-25   
CiplaAlendronate Alendronate  2008-08-04   
Raloxifene Raloxifene  2014-09-24   
SandozZoledronic acid Aclasta  2005-04-15   
Ibandronic acid Ibandronic Acid Sandoz  2011-07-26   
OrganonAlendronic acid, Colecalciferol Adrovance  2007-01-04   
Alendronate Fosamax  1995-09-29 $149 M Q4/23-Q3/24 
Alendronate, Cholecalciferol Fosamax D  2005-04-07   
Alendronic acid, Colecalciferol Fosavance  2005-08-24   
Alendronic acid, Colecalciferol Vantavo (previously Alendronate colecalciferol, MSD)  2009-10-16   
SanofiTeriparatide Parathar  1987-12-23   
UCBRomosozumab Evenity  2019-12-09   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
42%
5/12
Phase 2
87%
20/23
Phase 3
70%
33/47
Approved: 19Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Alendronate
Mylan
Alendronate
Roche
Ibandronic acid,
Ibandronate,
Risedronic acid,
Retinol,
Ccb,
Collastat,
Prp
Sandoz
Denosumab
Organon
Alendronic acid,
Colecalciferol,
Alendronate,
Cholecalciferol,
Calcium carbonate,
Risedronic acid,
Retinol,
Ccb,
Tums,
Antacid
Novartis
Pamidronate,
Calcitonin,
Maltodextrin,
Pth134,
Cgrp
Sanofi
Teriparatide,
Aspartame,
Etidronic acid,
Risedronic acid,
Ccb
UCB
Romosozumab
Merck & Co
Alendronate,
Calcium carbonate,
Odanacatib,
Ademetionine,
Retinol,
Tums,
Antacid,
MK0429
Pfizer
Bazedoxifene,
Retinol,
Viviant
Eli Lilly
Teriparatide,
Raloxifene,
Benzocaine,
Ademetionine,
Calcitonin,
Doconexent,
Arzoxifene,
Strontium ranelate,
BLOSOZUMAB,
Etidronic acid,
Risedronic acid,
Retinol,
Maltodextrin,
Ccb,
Strontium,
Cgrp
Dr Reddys Laboratories
Ibandronate
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use